Sterling Capital Management’s TriSalus Life Sciences TLSI Stock Holding History

Sterling Capital Management’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$764	Sell	168 -572	-77%	-$2.27K	﹤0.01%	3180
2026 Q1	$2.96K	Sell	740 -631	-46%	-$3.09K	﹤0.01%	2897
2025 Q4	$9.57K	Buy	1,371 +373	+37%	+$2.09K	﹤0.01%	2623
2025 Q3	$4.64K	Buy	998 +659	+194%	+$3.09K	﹤0.01%	2784
2025 Q2	$1.85K	Buy	+339	New	+$1.82K	﹤0.01%	2936

Other funds holding TLSI

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Sterling Capital Management's TLSI Position: Q2 2026 in Review

Sterling Capital Management reduced its TriSalus Life Sciences (TLSI) stake by 77% in Q2 2026, selling an estimated $2.27K and leaving 168 shares worth $764. The position accounts for ﹤0.01% of the portfolio, ranked #3180.

Sterling Capital Management first reported a position in TLSI in Q2 2025 and has held it in 5 quarters since. The position peaked at $9.57K in Q4 2025. 79 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

Sterling Capital Management held 168 shares of TriSalus Life Sciences worth $764 as of Q2 2026.
Sterling Capital Management sold 572 TriSalus Life Sciences shares in Q2 2026, an estimated $2.27K.
TriSalus Life Sciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #3180 holding.
Sterling Capital Management first reported a position in TriSalus Life Sciences in Q2 2025 and has held it in 5 quarters since.
Sterling Capital Management's TriSalus Life Sciences position peaked at $9.57K in Q4 2025.
79 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.